✦ LIBER ✦

Retinoic Acid and Histone Deacetylase Inhibitor BML-210 Inhibit Proliferation of Human Cervical Cancer HeLa Cells

✍ Scribed by VERONIKA V. BORUTINSKAITE; RUTA NAVAKAUSKIENE; KARL-ERIC MAGNUSSON

Book ID: 111480729
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 706 KB
Volume: 1091
Category: Article
ISSN: 0890-6564
DOI: 10.1196/annals.1378.079

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Histone deacetylase inhibitor BML-210 in

Histone deacetylase inhibitor BML-210 induces growth inhibition and apoptosis and regulates HDAC and DAPC complex expression levels in cervical cancer cells

✍ Veronika V. Borutinskaite, Karl-Eric Magnusson… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 521 KB

Histone deacetylase inhibitors and retin

Histone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro

✍ Coffey, Dennis C. ;Kutko, Martha C. ;Glick, Richard D. ;Swendeman, Steven L. ;Bu 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

## Background: Neuroblastoma is a common childhood cancer with a poor overall prognosis. retinoic acids (ras) have been studied as a potential therapy, showing promise in recurrent disease. the histone deacetylase inhibitor (hdaci) m-carboxycinnamic acid bishydroxamide (cbha) is another potential t

Histone deacetylase inhibitor, suberoyla

Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells

✍ Takashi Kumagai; Naoki Wakimoto; Dong Yin; Sigal Gery; Norihiko Kawamata; Noriyu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 461 KB 👁 1 views

## Abstract Tumor suppressor genes are often silenced in human cancer; this can occur by transcriptional repression by deacetylation in the promoter regions, mediated by histone deacetylase (HDAC). HDAC inhibitors can block cancer cell growth by restoring expression of tumor suppressor genes. In th

GROWTH INHIBITION OF RENAL CANCER CELLS

GROWTH INHIBITION OF RENAL CANCER CELLS BY HISTONE DEACETYLASE INHIBITORS, SUBEROYLANILIDE HYDROXAMIC ACID (SAHA) AND PXD101

✍ Min, Gyeong Eun; Hwang, Jung Jin; Yoo, Changhee; Kim, Mi-Joung; Kim, Yong-Sook; 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 122 KB

Novel Inhibitors of Human Histone Deacet

Novel Inhibitors of Human Histone Deacetylases: Design, Synthesis, Enzyme Inhibition, and Cancer Cell Growth Inhibition of SAHA-Based Non-hydroxamates

✍ Suzuki, Takayoshi; Nagano, Yuki; Kouketsu, Akiyasu; Matsuura, Azusa; Maruyama, S 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 319 KB

The histone deacetylase inhibitor, suber

The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL

✍ Lisa M. Butler; Vasilios Liapis; Stelios Bouralexis; Katie Welldon; Shelley Hay; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 958 KB

## Abstract While the apoptosis‐inducing ligand Apo2L/TRAIL is a promising new agent for the treatment of cancer, the sensitivity of cancer cells for induction of apoptosis by Apo2L/TRAIL varies considerably. Identification of agents that can be used in combination with Apo2L/TRAIL to enhance apopt